Most Recent
While acknowledging it was a ‘loaded’ word, a judge has rejected a bid by the federal government to edit out the word 'stolen' from a notice to members of the third stolen wages class action brought by Shine Lawyers.
A judge hearing a price-fixing case against steel giant BlueScope has overruled an objection to the ACCCs barrister's allegedly excessive "eye-rolling" and "scathing and sarcastic" manner during a cross-examination in which the company's general manager was accused of lying under oath.
The Federal Court's decision that artificial intelligence can be listed on a patent application as the inventor has become an outlier, as the UK joins the US in rejecting what has become an international battle to claim AI inventorship.
Iconic Australian beer manufacturer Carlton & United Breweries has lost an appeal seeking to shield information about 1,500 allegedly privileged documents from the Australian Taxation Office.
Supermarket giant Woolworths has denied the Fair Work Ombudsman is entitled to seek compensation for its underpayment of staff, saying its $330 million remediation to affected employees fully answers the regulator's case.
A judge has questioned whether he should allow prosecutors to amend charges against ANZ and its treasurer in a criminal cartel case over a $2.5 billion share placement after the bank argued the charges were defective and should be quashed.
A judge has rebuked the Morrison government for approving a gas exploration contract with a subsidiary of Empire Energy in the Beetaloo basin without notifying the environmental organisation leading a climate change lawsuit over the project.
Assessing claims of privilege involving multidisciplinary firms like PricewaterhouseCoopers that offer legal and accounting services is "inherently awkward", a court heard on the final day of a hearing in a privilege battle between the accounting firm and the ATO.
A PwC partner who the ATO claims was assigned to work on a matter for meat processing company JBS to bring a “cloak of legal privilege” kept a supporting role on the brief despite the company CFO’s dissatisfaction, a court has heard.
Merck Sharp & Dohme is seeking to overturn a judgment refusing an extension of a patent covering its Januvia and Janumet diabetes drugs that would have seen the US drug maker of retaining a monopoly over the multibillion dollar medicines beyond July 2022.